Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Other financing activities: 2022-2025

  • Centessa Pharmaceuticals' Other financing activities was N/A to $4.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$6.0 million, marking a year-over-year change of. This contributed to the annual value of -$5.3 million for FY2024, which is N/A change from last year.
  • As of Q2 2025, Centessa Pharmaceuticals' Other financing activities stood at $4.4 million, which was up 191.73% from -$4.8 million recorded in Q1 2025.
  • In the past 5 years, Centessa Pharmaceuticals' Other financing activities registered a high of $4.4 million during Q2 2025, and its lowest value of -$5.3 million during Q4 2024.
  • Over the past 2 years, Centessa Pharmaceuticals' median Other financing activities value was -$4.8 million (recorded in 2025), while the average stood at -$1.9 million.